Marketplace Morning Report

with David Brancaccio

Marketplace Morning Report for Thursday, April 11, 2013

Biogen Idec, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug Tecfidera will eventually bring in the hundreds of millions of dollars it cost to develop -- at least before a generic comes along and copies it. CEO George Scangos discusses his company's development process and pricing strategy. A new report from the research firm IDC says personal computer sales are falling fast all around the world. And in Phoenix, Arizona, new signs of a real estate bubble are emerging.

Listen to the episode
Download

From this Episode

Music from this Show

Browse the Show
David Brancaccio
Brancaccio david

About the Show

News happens while you sleep. Marketplace Morning Report gives you a head start on the day. Throughout the morning, host David Brancaccio shares the latest on markets, money, jobs and innovation, providing the context you need to make the smartest decisions. And from London, host Anu Anand presents Marketplace Morning Report from BBC World Service to bring you up to speed as the global economy shifts. It's the world perspective you need, from two trusted sources.